ID   L2HDH_HUMAN             Reviewed;         463 AA.
AC   Q9H9P8; Q9BRR1;
DT   21-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   10-MAY-2017, entry version 127.
DE   RecName: Full=L-2-hydroxyglutarate dehydrogenase, mitochondrial;
DE            EC=1.1.99.2;
DE   AltName: Full=Duranin;
DE   Flags: Precursor;
GN   Name=L2HGDH; Synonyms=C14orf160;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS L2HGA GLU-81 AND
RP   ASP-176, AND CHARACTERIZATION OF VARIANTS L2HGA GLU-81 AND ASP-176.
RX   PubMed=15548604; DOI=10.1073/pnas.0404840101;
RA   Rzem R., Veiga-da-Cunha M., Noel G., Goffette S., Nassogne M.-C.,
RA   Tabarki B., Schoeller C., Marquardt T., Vikkula M.,
RA   van Schaftingen E.;
RT   "A gene encoding a putative FAD-dependent L-2-hydroxyglutarate
RT   dehydrogenase is mutated in L-2-hydroxyglutaric aciduria.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:16849-16854(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   ARG-18.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR
RP   LOCATION, AND COFACTOR.
RX   PubMed=16005139; DOI=10.1016/j.biochi.2005.06.005;
RA   Rzem R., Van Schaftingen E., Veiga-da-Cunha M.;
RT   "The gene mutated in L-2-hydroxyglutaric aciduria encodes L-2-
RT   hydroxyglutarate dehydrogenase.";
RL   Biochimie 88:113-116(2006).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-155, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   VARIANTS L2HGA ASP-55; TYR-98 AND LEU-302, AND TISSUE SPECIFICITY.
RX   PubMed=15385440; DOI=10.1093/hmg/ddh300;
RA   Topcu M., Jobard F., Halliez S., Coskun T., Yalcinkayal C.,
RA   Gerceker F.O., Wanders R.J.A., Prud'homme J.-F., Lathrop M., Ozguc M.,
RA   Fischer J.;
RT   "L-2-hydroxyglutaric aciduria: identification of a mutant gene
RT   C14orf160, localized on chromosome 14q22.1.";
RL   Hum. Mol. Genet. 13:2803-2811(2004).
RN   [11]
RP   VARIANTS L2HGA ARG-57; ARG-98; LEU-302 AND PRO-434, AND VARIANTS
RP   ARG-18 AND PHE-178.
RX   PubMed=16134148; DOI=10.1002/humu.9373;
RA   Vilarinho L., Cardoso M.L., Gaspar P., Barbot C., Azevedo L.,
RA   Diogo L., Santos M., Carrilho I., Fineza I., Kok F., Chorao R.,
RA   Alegria P., Martins E., Teixeira J., Cabral-Fernandes H.,
RA   Verhoeven N.M., Salomons G.S., Santorelli F.M., Cabral P., Amorim A.,
RA   Jakobs C.;
RT   "Novel L2HGDH mutations in 21 patients with L-2-hydroxyglutaric
RT   aciduria of Portuguese origin.";
RL   Hum. Mutat. 26:395-396(2005).
CC   -!- CATALYTIC ACTIVITY: (S)-2-hydroxyglutarate + acceptor = 2-
CC       oxoglutarate + reduced acceptor. {ECO:0000269|PubMed:16005139}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:16005139};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=800 uM for L-2-hydroxyglutarate
CC         {ECO:0000269|PubMed:16005139};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:16005139}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H9P8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H9P8-2; Sequence=VSP_017662, VSP_017663;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in brain,
CC       testis and muscle. Expressed to a lower extent in lymphocytes,
CC       fibroblasts, keratinocytes, placenta, bladder, small intestine,
CC       liver and bone marrow. {ECO:0000269|PubMed:15385440}.
CC   -!- DISEASE: L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792]: A rare
CC       autosomal recessive disorder clinically characterized by mild
CC       psychomotor delay in the first years of life, followed by
CC       progressive cerebellar ataxia, dysarthria and moderate to severe
CC       mental retardation. Diagnosis is based on the presence of an
CC       excess of L-2-hydroxyglutaric acid in urine, blood and
CC       cerebrospinal fluid. {ECO:0000269|PubMed:15385440,
CC       ECO:0000269|PubMed:15548604, ECO:0000269|PubMed:16134148}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: Was named 'duranin' in honor of Marinus Duran, who
CC       first described L-2-hydroxyglutaric aciduria.
CC   -!- SIMILARITY: Belongs to the L2HGDH family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY757363; AAV52330.1; -; mRNA.
DR   EMBL; AK022680; BAB14174.1; -; mRNA.
DR   EMBL; AL109758; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359397; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006117; AAH06117.1; -; mRNA.
DR   CCDS; CCDS9698.1; -. [Q9H9P8-1]
DR   RefSeq; NP_079160.1; NM_024884.2. [Q9H9P8-1]
DR   RefSeq; XP_005268132.1; XM_005268075.4. [Q9H9P8-1]
DR   UniGene; Hs.256034; -.
DR   ProteinModelPortal; Q9H9P8; -.
DR   BioGrid; 123016; 14.
DR   IntAct; Q9H9P8; 1.
DR   STRING; 9606.ENSP00000267436; -.
DR   iPTMnet; Q9H9P8; -.
DR   PhosphoSitePlus; Q9H9P8; -.
DR   BioMuta; L2HGDH; -.
DR   DMDM; 317373422; -.
DR   EPD; Q9H9P8; -.
DR   MaxQB; Q9H9P8; -.
DR   PaxDb; Q9H9P8; -.
DR   PeptideAtlas; Q9H9P8; -.
DR   PRIDE; Q9H9P8; -.
DR   DNASU; 79944; -.
DR   Ensembl; ENST00000267436; ENSP00000267436; ENSG00000087299. [Q9H9P8-1]
DR   Ensembl; ENST00000421284; ENSP00000405559; ENSG00000087299. [Q9H9P8-1]
DR   GeneID; 79944; -.
DR   KEGG; hsa:79944; -.
DR   UCSC; uc001wxu.4; human. [Q9H9P8-1]
DR   CTD; 79944; -.
DR   DisGeNET; 79944; -.
DR   GeneCards; L2HGDH; -.
DR   H-InvDB; HIX0011640; -.
DR   HGNC; HGNC:20499; L2HGDH.
DR   HPA; HPA065409; -.
DR   HPA; HPA069708; -.
DR   MalaCards; L2HGDH; -.
DR   MIM; 236792; phenotype.
DR   MIM; 609584; gene.
DR   neXtProt; NX_Q9H9P8; -.
DR   OpenTargets; ENSG00000087299; -.
DR   Orphanet; 79314; L-2-hydroxyglutaric aciduria.
DR   PharmGKB; PA134971279; -.
DR   eggNOG; KOG2665; Eukaryota.
DR   eggNOG; COG0579; LUCA.
DR   GeneTree; ENSGT00490000043421; -.
DR   HOGENOM; HOG000245180; -.
DR   HOVERGEN; HBG081883; -.
DR   InParanoid; Q9H9P8; -.
DR   KO; K00109; -.
DR   OMA; GVHFTRM; -.
DR   OrthoDB; EOG091G06OM; -.
DR   PhylomeDB; Q9H9P8; -.
DR   TreeFam; TF105922; -.
DR   BRENDA; 1.1.99.2; 2681.
DR   Reactome; R-HSA-880009; Interconversion of 2-oxoglutarate and 2-hydroxyglutarate.
DR   ChiTaRS; L2HGDH; human.
DR   GeneWiki; L2HGDH; -.
DR   GenomeRNAi; 79944; -.
DR   PRO; PR:Q9H9P8; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000087299; -.
DR   CleanEx; HS_L2HGDH; -.
DR   ExpressionAtlas; Q9H9P8; baseline and differential.
DR   Genevisible; Q9H9P8; HS.
DR   GO; GO:0016021; C:integral component of membrane; IDA:HGNC.
DR   GO; GO:0031305; C:integral component of mitochondrial inner membrane; NAS:HGNC.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HGNC.
DR   GO; GO:0047545; F:2-hydroxyglutarate dehydrogenase activity; IDA:HGNC.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; TAS:Reactome.
DR   GO; GO:0044267; P:cellular protein metabolic process; IDA:HGNC.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   Pfam; PF01266; DAO; 1.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; FAD; Flavoprotein; Mitochondrion; Oxidoreductase;
KW   Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1     51       Mitochondrion. {ECO:0000255}.
FT   CHAIN        52    463       L-2-hydroxyglutarate dehydrogenase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000228129.
FT   MOD_RES     104    104       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q91YP0}.
FT   MOD_RES     155    155       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     173    173       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q91YP0}.
FT   VAR_SEQ     400    400       G -> QVAVRGPSWLWQQPMKVSDNNIYCFLWRCFALLLTG
FT                                STCSFK (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_017662.
FT   VAR_SEQ     401    463       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_017663.
FT   VARIANT      18     18       L -> R (in dbSNP:rs2275591).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:16134148}.
FT                                /FTId=VAR_025681.
FT   VARIANT      33     33       R -> S (in dbSNP:rs35710558).
FT                                /FTId=VAR_057808.
FT   VARIANT      55     55       G -> D (in L2HGA; dbSNP:rs118204021).
FT                                {ECO:0000269|PubMed:15385440}.
FT                                /FTId=VAR_025682.
FT   VARIANT      57     57       G -> R (in L2HGA; dbSNP:rs199690954).
FT                                {ECO:0000269|PubMed:16134148}.
FT                                /FTId=VAR_025683.
FT   VARIANT      81     81       K -> E (in L2HGA; alters protein
FT                                processing and abolishes catalytic
FT                                activity). {ECO:0000269|PubMed:15548604}.
FT                                /FTId=VAR_025684.
FT   VARIANT      98     98       H -> R (in L2HGA; dbSNP:rs267607206).
FT                                {ECO:0000269|PubMed:16134148}.
FT                                /FTId=VAR_025685.
FT   VARIANT      98     98       H -> Y (in L2HGA).
FT                                {ECO:0000269|PubMed:15385440}.
FT                                /FTId=VAR_025686.
FT   VARIANT     176    176       E -> D (in L2HGA; alters protein
FT                                processing and abolishes catalytic
FT                                activity). {ECO:0000269|PubMed:15548604}.
FT                                /FTId=VAR_025687.
FT   VARIANT     178    178       Y -> F (in dbSNP:rs770542189).
FT                                {ECO:0000269|PubMed:16134148}.
FT                                /FTId=VAR_025688.
FT   VARIANT     302    302       P -> L (in L2HGA; dbSNP:rs118204020).
FT                                {ECO:0000269|PubMed:15385440,
FT                                ECO:0000269|PubMed:16134148}.
FT                                /FTId=VAR_025689.
FT   VARIANT     434    434       H -> P (in L2HGA; dbSNP:rs750044734).
FT                                {ECO:0000269|PubMed:16134148}.
FT                                /FTId=VAR_025690.
SQ   SEQUENCE   463 AA;  50316 MW;  1B6BC0C88543B7FF CRC64;
     MVPALRYLVG ACGRARGLFA GGSPGACGFA SGRPRPLCGG SRSASTSSFD IVIVGGGIVG
     LASARALILR HPSLSIGVLE KEKDLAVHQT GHNSGVIHSG IYYKPESLKA KLCVQGAALL
     YEYCQQKGIS YKQCGKLIVA VEQEEIPRLQ ALYEKGLQNG VPGLRLIQQE DIKKKEPYCR
     GLMAIDCPHT GIVDYRQVAL SFAQDFQEAG GSVLTNFEVK GIEMAKESPS RSIDGMQYPI
     VIKNTKGEEI RCQYVVTCAG LYSDRISELS GCTPDPRIVP FRGDYLLLKP EKCYLVKGNI
     YPVPDSRFPF LGVHFTPRMD GSIWLGPNAV LAFKREGYRP FDFSATDVMD IIINSGLIKL
     ASQNFSYGVT EMYKACFLGA TVKYLQKFIP EITISDILRG PAGVRAQALD RDGNLVEDFV
     FDAGVGDIGN RILHVRNAPS PAATSSIAIS GMIADEVQQR FEL
//
